Wacker Biotech GmbH
Jena, Germany
Wacker Biotech GmbH in Jena, Germany, produces biologics for well-known pharmaceutical and biotechnology companies and operates a highly specialized production facility geared toward contract development and manufacturing for therapeutic proteins. At our site in Jena, we collaborate with a variety of companies and organizations in order to secure steady growth in the region and ongoing success for our customers. We are also proud of the solutions we develop here, which play a critical role in treating severe disease. Our products include asparaginase, for instance, which is sold under the brand name Spectrila and used for treating lymphocytic leukemia in children and teens.
Jena: an Established Science Hub in Germany
Learn More about Biologics from WACKER
The university city of Jena is one of Germany’s key science hubs. Important research institutes belonging to the Max Planck Society, the Fraunhofer-Gesellschaft and the Leibniz Association call Jena home, as do a number of biotech and medical technology companies. This unique network fosters lively discourse between business and science. Its location among the science institutions on the Beutenberg Campus gives Wacker Biotech GmbH an important regional research partner. A pioneer in the chemical industry, WACKER likewise operates an important production and research site in Jena, manufacturing products such as high-quality biologics based on microbial systems since 2005.
Jobs & Careers
WACKER in Jena is a successful innovator in the biotech industry. Our Beutenberg Campus location offers modern workplaces, specialized equipment and a wide array of career opportunities. The campus is home to two cafeterias and a commuter bike program providing a convenient way of connecting to public transit. We promote equal opportunities and encourage teamwork and community within our interdepartmental projects. Take a look at our open positions and apply today!
View positions
Site-Specific Facts & Figures
- Name: Wacker Biotech GmbH
- Site: Jena
- Employees: approx. 140
- Products: recombinant proteins (contract manufacturing), pharmaceutical actives for clinical testing and the commercial market
- The facility is certified in accordance with good manufacturing practice (GMP) and complies with the requirements stipulated by the European and US drug-approval authorities (EMA and FDA, respectively).
